Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome

doi:10.3748/wjg.v29.i28.4451

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8466)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

211

WORD

HTML

5277

Figures (1-3)

436

Tables (1-3)

413

Sum=6389

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

199

Download

645

Sum=844

Publishing Process of This Article

Item

Count

Browse

178

Download

658

Sum=836

Jul 28, 2023 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Jul 28, 2023; 29(28): 4451-4465
Published online Jul 28, 2023. doi: 10.3748/wjg.v29.i28.4451

Full Size Figure Download Figure

Figure 3 Fecal microbial profile over the intervention period. A: Proportional family level abundance in participants receiving placebo or Lactiplantibacillus plantarum (L. plantarum) (1B or 10B CFU) capsules; B: Proportional genus level abundance in participants receiving placebo or L. plantarum (1B or 10B CFU) capsules.

Citation: Martoni CJ, Srivastava S, Damholt A, Leyer GJ. Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2023; 29(28): 4451-4465
URL: https://www.wjgnet.com/1007-9327/full/v29/i28/4451.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i28.4451